Literature DB >> 24992143

The inflammasome and lupus: another innate immune mechanism contributing to disease pathogenesis?

J Michelle Kahlenberg1, Mariana J Kaplan.   

Abstract

PURPOSE OF REVIEW: The role of innate immunity in systemic lupus erythematosus (SLE) has been a rapidly expanding area of research over the last decade. Included in this rubric is the concept that activation of the inflammasome, a molecular complex that activates caspase-1 and in turn the cytokines IL-1β and IL-18, is important in lupus pathogenesis. This review will summarize the recent discoveries exploring the role of the inflammasome machinery in SLE. RECENT
FINDINGS: Immune complexes can activate the NLRP3 inflammasome, and SLE-derived macrophages are hyper-responsive to innate immune stimuli, leading to enhanced activation of the inflammasome and production of inflammatory cytokines. Work in several murine models suggests an important role for the NLRP3 inflammasome in mediating lupus nephritis. Caspase-1, the central enzyme of the inflammasome, is essential for the development of type I interferon responses, autoantibody production, and nephritis in the pristane model of lupus. The absence of melanoma 2 inflammasome may have protective and pathogenic roles in SLE.
SUMMARY: Recent evidence suggests that the inflammasome machinery is dysregulated in SLE, plays an important role in promotion of organ damage, and may mediate cross-talk between environmental triggers and the development of lupus. Further research should focus on whether inhibition of inflammasome components may serve as a viable target for therapeutic development in SLE.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24992143      PMCID: PMC4153426          DOI: 10.1097/BOR.0000000000000088

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  67 in total

1.  Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus.

Authors:  Eneida Villanueva; Srilakshmi Yalavarthi; Celine C Berthier; Jeffrey B Hodgin; Ritika Khandpur; Andrew M Lin; Cory J Rubin; Wenpu Zhao; Stephen H Olsen; Matthew Klinker; David Shealy; Michael F Denny; Joel Plumas; Laurence Chaperot; Matthias Kretzler; Allen T Bruce; Mariana J Kaplan
Journal:  J Immunol       Date:  2011-05-25       Impact factor: 5.422

2.  Human keratinocytes respond to interleukin-18: implication for the course of chronic inflammatory skin diseases.

Authors:  Miriam Wittmann; Rahul Purwar; Christina Hartmann; Ralf Gutzmer; Thomas Werfel
Journal:  J Invest Dermatol       Date:  2005-06       Impact factor: 8.551

3.  Molecular mechanism for p202-mediated specific inhibition of AIM2 inflammasome activation.

Authors:  Qian Yin; David P Sester; Yuan Tian; Yu-Shan Hsiao; Alvin Lu; Jasmyn A Cridland; Vitaliya Sagulenko; Sara J Thygesen; Divaker Choubey; Veit Hornung; Thomas Walz; Katryn J Stacey; Hao Wu
Journal:  Cell Rep       Date:  2013-07-11       Impact factor: 9.423

4.  Inflammasome is a central player in the induction of obesity and insulin resistance.

Authors:  Rinke Stienstra; Janna A van Diepen; Cees J Tack; Md Hasan Zaki; Frank L van de Veerdonk; Deshani Perera; Geoffrey A Neale; Guido J Hooiveld; Anneke Hijmans; Irene Vroegrijk; Sjoerd van den Berg; Johannes Romijn; Patrick C N Rensen; Leo A B Joosten; Mihai G Netea; Thirumala-Devi Kanneganti
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-29       Impact factor: 11.205

5.  Antroquinonol differentially modulates T cell activity and reduces interleukin-18 production, but enhances Nrf2 activation, in murine accelerated severe lupus nephritis.

Authors:  Pei-Yi Tsai; Shuk-Man Ka; Jia-Ming Chang; Jenn-Haung Lai; Ming-Shen Dai; Huei-Lin Jheng; Mao-Tien Kuo; Peini Chen; Ann Chen
Journal:  Arthritis Rheum       Date:  2012-01

Review 6.  P2 receptors and extracellular ATP: a novel homeostatic pathway in inflammation.

Authors:  Martijn Jan Leo Bours; Pieter Cornelis Dagnelie; Anna Lisa Giuliani; Anke Wesselius; Francesco Di Virgilio
Journal:  Front Biosci (Schol Ed)       Date:  2011-06-01

7.  AIM2 facilitates the apoptotic DNA-induced systemic lupus erythematosus via arbitrating macrophage functional maturation.

Authors:  Weijuan Zhang; Yanxing Cai; Wei Xu; Zhinan Yin; Xiaoming Gao; Sidong Xiong
Journal:  J Clin Immunol       Date:  2013-03-12       Impact factor: 8.317

Review 8.  Association of interleukin-18 (-137G/C) polymorphism with rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis.

Authors:  Dan Wen; Jun Liu; Xin Du; Jian-Zeng Dong; Chang-Sheng Ma
Journal:  Int Rev Immunol       Date:  2013-08-05       Impact factor: 5.311

9.  Neutrophil extracellular trap-associated protein activation of the NLRP3 inflammasome is enhanced in lupus macrophages.

Authors:  J Michelle Kahlenberg; Carmelo Carmona-Rivera; Carolyne K Smith; Mariana J Kaplan
Journal:  J Immunol       Date:  2012-12-24       Impact factor: 5.422

10.  Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria.

Authors:  Edward A Miao; Irina A Leaf; Piper M Treuting; Dat P Mao; Monica Dors; Anasuya Sarkar; Sarah E Warren; Mark D Wewers; Alan Aderem
Journal:  Nat Immunol       Date:  2010-11-07       Impact factor: 25.606

View more
  59 in total

Review 1.  Metabolic abnormalities and oxidative stress in lupus.

Authors:  Yaima L Lightfoot; Luz P Blanco; Mariana J Kaplan
Journal:  Curr Opin Rheumatol       Date:  2017-09       Impact factor: 5.006

2.  TLR7-Mediated Lupus Nephritis Is Independent of Type I IFN Signaling.

Authors:  Sonya J Wolf; Jonathan Theros; Tammi J Reed; Jianhua Liu; Irina L Grigorova; Giovanny Martínez-Colón; Chaim O Jacob; Jeffrey B Hodgin; J Michelle Kahlenberg
Journal:  J Immunol       Date:  2018-06-08       Impact factor: 5.422

3.  Cholesterol Accumulation in Dendritic Cells Links the Inflammasome to Acquired Immunity.

Authors:  Marit Westerterp; Emmanuel L Gautier; Anjali Ganda; Matthew M Molusky; Wei Wang; Panagiotis Fotakis; Nan Wang; Gwendalyn J Randolph; Vivette D D'Agati; Laurent Yvan-Charvet; Alan R Tall
Journal:  Cell Metab       Date:  2017-05-04       Impact factor: 27.287

Review 4.  Environmental Basis of Autoimmunity.

Authors:  Annarosa Floreani; Patrick S C Leung; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2016-06       Impact factor: 8.667

Review 5.  An update on lupus animal models.

Authors:  Wei Li; Anton A Titov; Laurence Morel
Journal:  Curr Opin Rheumatol       Date:  2017-09       Impact factor: 5.006

6.  Protection against lupus-like inflammatory disease is in the LAP of non-canonical autophagy.

Authors:  Thomas Scambler; Conor Feeley; Michael F McDermott
Journal:  Ann Transl Med       Date:  2016-12

7.  Epigenome profiling reveals significant DNA demethylation of interferon signature genes in lupus neutrophils.

Authors:  Patrick Coit; Srilakshmi Yalavarthi; Mikhail Ognenovski; Wenpu Zhao; Sarfaraz Hasni; Jonathan D Wren; Mariana J Kaplan; Amr H Sawalha
Journal:  J Autoimmun       Date:  2015-01-28       Impact factor: 7.094

8.  Differential expression of the inflammasome complex genes in systemic lupus erythematosus.

Authors:  Heidi Lacerda Alves da Cruz; Catarina Addobbati Jordão Cavalcanti; Jaqueline de Azêvedo Silva; Camilla Albertina Dantas de Lima; Thiago Sotero Fragoso; Alexandre Domingues Barbosa; Andréa Tavares Dantas; Henrique de Ataíde Mariz; Angela Luzia Branco Pinto Duarte; Alessandra Pontillo; Sergio Crovella; Paula Sandrin-Garcia
Journal:  Immunogenetics       Date:  2020-02-05       Impact factor: 2.846

9.  Upregulation of NLRP3 inflammasome components in Mooren's ulcer.

Authors:  Zhiyuan Li; Chao Wei; Shuang Wang; Ting Liu; Hualei Zhai; Weiyun Shi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-10-28       Impact factor: 3.117

10.  Enhanced Inflammasome Activity in Systemic Lupus Erythematosus Is Mediated via Type I Interferon-Induced Up-Regulation of Interferon Regulatory Factor 1.

Authors:  Jianhua Liu; Celine C Berthier; J Michelle Kahlenberg
Journal:  Arthritis Rheumatol       Date:  2017-08-08       Impact factor: 10.995

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.